Companies: 10,795·Total market cap: $144.5T

Herantis Pharma Oyj

Herantis Pharma Oyj

HRPMFOTCHealthcare

$3.51

+$0.00(+0.00%)

Market Cap$59465016

P/E Ratio—

52W High$3.51

52W Low$3.51

Avg Volume0

Open$3.51

Beta0.43

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Herantis Pharma Oyj（HRPMF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HRPMF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.23Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding20.2MShares outstanding history

Next EarningsTBAEarnings history

探索 Herantis Pharma Oyj 数据

分析师预测—

股息不分红

盈利EPS $-0.24-1572.39%

财务快照

FY 2024Revenue$0.00

202220232024

FY 2024Net Income-$4.9M▼ 1864.94% YoY

202220232024

FY 2024EPS$-0.24▼ 1572.39% YoY

202220232024

TTM:Revenue: $0.00Net Income: -$4.8MEPS: $-0.23View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Herantis Pharma Oyj

$3.51+0.00%$59.5M #2

$4.03+0.75%$57.8M #3

Small Pharma Inc.

$0.11-9.69%$37.5M #4

Elegance Optical International Holdings Limited

$0.07+0.00%$63.4M #5

Goodness Growth Holdings, Inc.

$0.45+0.00%$61.0M #6

Karolinska Development AB (publ)

$0.26+0.00%$68.9M

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y+0.00%

关于 Herantis Pharma Oyj

CEOAntti Vuolanto D.Sc. (Tech)

IPO DateOct 30, 2018

Employees10

CountryFI

Websiteherantis.com

Herantis Pharma Oyj a biotechnology enterprise, specializes in creating disease-modifying therapies for Parkinson's disease (PD) that harness Cerebral Dopamine Neurotrophic Factor (CDNF). Central to …

Biotechnology HealthcareOTCFI

关于股票概览与关键数据

Herantis Pharma Oyj（HRPMF）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 30, 2018 在 OTC 上市。截至最近交易日，HRPMF 股价为 $3.51，市值约为 $59.5M。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2024 财年 Herantis Pharma Oyj 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Herantis Pharma Oyj（HRPMF）股价为 $3.51，在 OTC 上市，52周区间为 $3.51 – $3.51。

HRPMF 最新股价HRPMF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议